References
- Fowler B. Homocysteine: overview of biochemistry, molecular biology, and role in disease processes. Semin Vasc Med. 2005;5(2):77–86. doi: 10.1055/s-2005-872394
- Froese DS, Fowler B, Baumgartner MR. Vitamin B12, folate, and the methionine remethylation cycle-biochemistry, pathways, and regulation. J Inherit Metab Dis. 2019;42(4):673–85. doi: 10.1002/jimd.12009
- Yap S, Naughten E. Homocystinuria due to cystathionine beta-synthase deficiency in Ireland: 25 years’ experience of a newborn screened and treated population with reference to clinical outcome and biochemical control. J Inherit Metab Dis. 1998;21(7):738–47. doi: 10.1023/a:1005445132327
- Morris AA, Kožich V, Santra S, Andria G, Ben-Omran TI, Chakrapani AB, et al. Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency. J Inherit Metab Dis. 2017;40(1):49–74. doi: 10.1007/s10545-016-9979-0
- Huemer M, Diodato D, Martinelli D, Olivieri G, Blom H, Gleich F, et al. Phenotype, treatment practice and outcome in the cobalamin-dependent remethylation disorders and MTHFR deficiency: Data from the E-HOD registry. J Inherit Metab Dis. 2019;42(2):333–52. doi: 10.1002/jimd.12041
- Huemer M, Baumgartner MR. The clinical presentation of cobalamin-related disorders: From acquired deficiencies to inborn errors of absorption and intracellular pathways. J Inherit Metab Dis. 2019;42(4):686–705. doi: 10.1002/jimd.12012
- Stabler SP. Clinical practice. Vitamin B12 deficiency. N Engl J Med. 2013;368(2):149–60. doi: 10.1056/NEJMcp1113996
- Watkins D, Rosenblatt DS. Inborn errors of cobalamin absorption and metabolism. Am J Med Genet C Semin Med Genet. 2011;157C(1):33–44. doi: 10.1002/ajmg.c.30288
- Martinelli D, Deodato F, Dionisi-Vici C. Cobalamin C defect: natural history, pathophysiology, and treatment. J Inherit Metab Dis. 2011;34(1):127–35. doi: 10.1007/s10545-010-9161-z
- Carrillo-Carrasco N, Chandler RJ, Venditti CP. Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management. J Inherit Metab Dis. 2012;35(1):91–102. doi: 10.1007/s10545-011-9364-y
- Rosenblatt DS, Aspler AL, Shevell MI, Pletcher BA, Fenton WA, Seashore MR. Clinical heterogeneity and prognosis in combined methylmalonic aciduria and homocystinuria (cblC). J Inherit Metab Dis. 1997;20(4):528–38. doi: 10.1023/a:1005353530303
- Acıpayam C, Güneş H, Güngör O, İpek S, Sarışık N, Demir NŞ. Cerebral atrophy in 21 hypotonic infants with severe vitamin B12 deficiency. J Paediatr Child Health. 2020;56(5):751–6. doi: 10.1111/jpc.14733
- Roschitz B, Plecko B, Huemer M, Biebl A, Foerster H, Sperl W. Nutritional infantile vitamin B12 deficiency: pathobiochemical considerations in seven patients. Arch Dis Child Fetal Neonatal Ed. 2005;90(3):F281–2. doi: 10.1136/adc.2004.061929
- Fischer S, Huemer M, Baumgartner M, Deodato F, Ballhausen D, Boneh A, et al. Clinical presentation and outcome in a series of 88 patients with the cblC defect. J Inherit Metab Dis. 2014;37(5):831–40. doi: 10.1007/s10545-014-9687-6
- Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet. 1985;37(1):1–31.
- Al-Dewik N, Ali A, Mahmoud Y, Shahbeck N, Ali R, Mahmoud L, et al. Natural history, with clinical, biochemical, and molecular characterization of classical homocystinuria in the Qatari population. J Inherit Metab Dis. 2019;42(5):818–30. doi: 10.1002/jimd.12099
- Huemer M, Diodato D, Schwahn B, Schiff M, Bandeira A, Benoist JF, et al. Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency. J Inherit Metab Dis. 2017;40(1):21–48. doi: 10.1007/s10545-016-9991-4
- Burda P, Kuster A, Hjalmarson O, Suormala T, Bürer C, Lutz SR, et al. Characterization and review of MTHFD1 deficiency: four new patients, cellular delineation and response to folic and folinic acid treatment. J Inherit Metab Dis. 2015;38(5):863–72. doi: 10.1007/s10545-015-9810-3
- Yu HC, Sloan JL, Scharer G, Brebner A, Quintana AM, Achilly NP, et al. An X-linked cobalamin disorder caused by mutations in transcriptional coregulator HCFC1. Am J Hum Genet. 2013;93(3):506–14. doi: 10.1016/j.ajhg.2013.07.022
- Quintana AM, Yu HC, Brebner A, Pupavac M, Geiger EA, Watson A, et al. Mutations in THAP11 cause an inborn error of cobalamin metabolism and developmental abnormalities. Hum Mol Genet. 2017;26(15):2838–49. doi: 10.1093/hmg/ddx157
- Chien YH, Abdenur JE, Baronio F, Bannick AA, Corrales F, Couce M, et al. Mudd’s disease (MAT I/III deficiency): a survey of data for MAT1A homozygotes and compound heterozygotes. Orphanet J Rare Dis. 2015;10:99. doi: 10.1186/s13023-015-0321-y
- Barić I, Staufner C, Augoustides-Savvopoulou P, Chien YH, Dobbelaere D, Grünert SC, et al. Consensus recommendations for the diagnosis, treatment and follow-up of inherited methylation disorders. J Inherit Metab Dis. 2017;40(1):5–20. doi: 10.1007/s10545-016-9972-7
- Bublil EM, Majtan T. Classical homocystinuria: from cystathionine beta-synthase deficiency to novel enzyme therapies. Biochimie. 2020;173:48–56. doi: 10.1016/j.biochi.2019.12.007
- Diekman EF, de Koning TJ, Verhoeven-Duif NM, Rovers MM, van Hasselt PM. Survival and psychomotor development with early betaine treatment in patients with severe methylenetetrahydrofolate reductase deficiency. JAMA Neurol. 2014;71(2):188–94. doi: 10.1001/jamaneurol.2013.4915
- Keller R, Chrastina P, Pavlíková M, Gouveia S, Ribes A, Kölker S, et al.; individual contributors of the European Network and Registry for Homocystinurias and Methylation Defects (E-HOD), Barić I, Ben-Omran T, Blasco-Alonso J, Bueno Delgado MA, Carducci C, Cassanello M, et al. Newborn screening for homocystinurias: Recent recommendations versus current practice. J Inherit Metab Dis. 2019;42(1):128–39. doi: 10.1002/jimd.12034
- Huemer M, Kožich V, Rinaldo P, Baumgartner MR, Merinero B, Pasquini E, et al. Newborn screening for homocystinurias and methylation disorders: systematic review and proposed guidelines. J Inherit Metab Dis. 2015;38(6):1007–19. doi: 10.1007/s10545-015-9830-z
- Schif M, Blom HJ. Treatment of inherited homocystinurias. Neuropediatrics. 2012;43(6):295–304. doi: 10.1055/s-0032-1329883
- Andersson HC, Shapira E. Biochemical and clinical response to hydroxocobalamin versus cyanocobalamin treatment in patients with methylmalonic acidemia and homocystinuria (cblC). J Pediatr. 1998;132(1):121–4. doi: 10.1016/s0022-3476(98)70496-2
- Froese DS, Kopec J, Fitzpatrick F, Schuller M, McCorvie TJ, Chalk R, et al. Structural Insights into the MMACHC-MMADHC protein complex involved in vitamin B12 trafficking. J Biol Chem. 2015;290(49):29167–77. doi: 10.1074/jbc.M115.683268
- Erbe RW, Salis RJ. Severe methylenetetrahydrofolate reductase deficiency, methionine synthase, and nitrous oxide – a cautionary tale. N Engl J Med. 2003;349(1):5–6. doi: 10.1056/NEJMp030093
- Selzer RR, Rosenblatt DS, Laxova R, Hogan K. Adverse effect of nitrous oxide in a child with 5,10-methylenetetrahydrofolate reductase deficiency. N Engl J Med. 2003;349(1):45–50. doi: 10.1056/NEJMoa021867
- Manoli I, Myles JG, Sloan JL, Carrillo-Carrasco N, Morava E, Strauss KA, et al. A critical reappraisal of dietary practices in methylmalonic acidemia raises concerns about the safety of medical foods. Part 2: cobalamin C deficiency. Genet Med. 2016;18(4):396–404. doi: 10.1038/gim.2015.107
- Weisfeld-Adams JD, Bender HA, Miley-Åkerstedt A, Frempong T, Schrager NL, Patel K, et al. Neurologic and neurodevelopmental phenotypes in young children with early-treated combined methylmalonic acidemia and homocystinuria, cobalamin C type. Mol Genet Metab. 2013;110(3):241–7. doi: 10.1016/j.ymgme.2013.07.018
- Matos IV, Castejón E, Meavilla S, O’Callaghan M, Garcia-Villoria J, López-Sala A, et al. Clinical and biochemical outcome after hydroxocobalamin dose escalation in a series of patients with cobalamin C deficiency. Mol Genet Metab. 2013;109(4):360–5. doi: 10.1016/j.ymgme.2013.05.007
- Trefz FK, Scheible D, Frauendienst-Egger G, Huemer M, Suomala T, Fowler B, et al. Successful intrauterine treatment of a patient with cobalamin C defect. Mol Genet Metab Rep. 2016;6:55–9. doi: 10.1016/j.ymgmr.2016.01.005